Skip to main content
  • English
  • Español
Oryzon
  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
      • Share Performance
      • Shares and Capital Structure
      • Dividends
      • Share Issues
      • Takeover Bids
      • Shareholdings
    • Financial Information
      • Financial Results and Accounts
      • Public Periodic Information
      • Average supplier payment period
    • Inside information
    • Other relevant information
    • Analyst Coverage
    • Corporate Governance
      • General Shareholders Meeting
      • Board of Directors
      • Board Committees
      • Shareholder Agreements
      • Annual Corporate Governance Reports
      • Annual Director Remuneration Reports
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us

Company

Breadcrumb

  1. Home
  2. Company
  3. Team

Meet our Team

Oryzon’s management team is composed of passionate biopharma executives exploring new fields of epigenetic science to transform it into innovative personalized medicines for patients. 

Management
  • Carlos Buesa

    Chief Executive Officer (CEO)
    see more
  • Torsten Hoffmann

    Chief Scientific Officer (CSO)
    see more
  • Michael Ropacki

    Vice President of Clinical and Product Development
    see more
  • Jordi Xaus

    Vice President of Clinical Portfolio and Innovation
    see more
  • Sonia Gutierrez

    Chief of Clinical Operations
    see more
  • Enric Rello

    Chief Operating Officer (COO), Chief Financial Officer (CFO)
    see more
  • Neus Virgili

    Chief Intellectual Property Officer (CIPO)
    see more
  • Emili Torrell

    Chief Business Development Officer (CBDO)
    see more
Board Members
  • Carlos Buesa

    President (Executive Director)
  • Tamara Maes

    First Deputy President (Dominical Director)
  • Ramón Adell Ramón

    Board Member (Independent Director)
  • Antonio Fornieles Melero

    Board Member (Independent Director)
  • Manuel López-Figueroa

    Board Member (Independent Director)
  • Isabel Aguilera Navarro

    Board Member (Independent Director)
  • Josep Ma Echarri Torres

    Board Member (Dominical Director)
Scientific Advisory Board
  • Dr. Tamara Maes

  • Dr. Howard Fillit

  • Dr. Felipe Prósper Cardoso

  • Dr. Leon Hooftman

  • Dr. Lori A. Kunkel

  • Company
    • Overview
    • Strategy
    • Team
  • Epigenetics
    • Epigenetics
    • LSD1
  • Programs
    • Pipeline
    • Iadademstat
    • Vafidemstat
    • Collaborations
    • Publications
  • Patients
    • Clinical Trials
  • Investors
    • Share Information
    • Financial Information
    • Inside information
    • Other relevant information
    • Analyst Coverage
    • Corporate Governance
    • Corporate Social Responsibility
  • News & Events
    • Press releases
    • Events
  • Contact
    • Contact
    • Email Alerts
    • Join us
  • © Oryzon Genomics, S.A. - All Rights Reserved

    • Legal
    • Privacy Policy
    • Cookie Policy